BIODESIX, INC. Increase (Decrease) in Contract with Customer, Liability
BIODESIX, INC. (BDSX) reported Increase (Decrease) in Contract with Customer, Liability of -$813.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-05
- BIODESIX, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$47.00K.
- BIODESIX, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$766.00K, a 1022.89% decline year-over-year.
- BIODESIX, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$1.84M.
- BIODESIX, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $2.13M, a 953.47% increase year-over-year.
- BIODESIX, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $174.00K, a 29.84% decline from fiscal 2024.
- BIODESIX, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was $248.00K.
- BIODESIX, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was -$755.00K.
- BIODESIX, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$1.21M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$813.00K 10-Q · filed 2026-08-05 | -$2.65M derived: sum of 3 quarters · filed 2026-08-05 | -$525.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$766.00K 10-Q · filed 2026-05-04 | -$2.61M derived: sum of 2 quarters · filed 2026-05-04 | -$478.00K derived: sum of 3 quarters · filed 2026-05-04 | -$675.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $288.00K derived: sum of 2 quarters · filed 2026-02-26 | $91.00K derived: sum of 3 quarters · filed 2026-08-05 | $174.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.93M derived: sum of 2 quarters · filed 2026-08-05 | $2.01M 10-Q · filed 2025-11-03 | $1.99M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$114.00K 10-Q · filed 2026-08-05 | -$139.00K derived: sum of 3 quarters · filed 2026-08-05 | $63.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $83.00K 10-Q · filed 2026-05-04 | $58.00K derived: sum of 2 quarters · filed 2026-05-04 | $260.00K derived: sum of 3 quarters · filed 2026-05-04 | $368.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $177.00K derived: sum of 2 quarters · filed 2026-02-26 | $285.00K derived: sum of 3 quarters · filed 2026-02-26 | $248.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $310.00K derived: sum of 2 quarters · filed 2025-11-03 | $273.00K 10-Q · filed 2025-11-03 | -$87.00K derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $71.00K 10-Q · filed 2025-08-07 | -$289.00K derived: sum of 3 quarters · filed 2025-08-07 | -$733.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$37.00K 10-Q · filed 2025-05-13 | -$397.00K derived: sum of 2 quarters · filed 2025-05-13 | -$841.00K derived: sum of 3 quarters · filed 2025-05-13 | -$921.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$804.00K derived: sum of 2 quarters · filed 2025-03-03 | -$884.00K derived: sum of 3 quarters · filed 2025-03-03 | -$755.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | -$444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$524.00K derived: sum of 2 quarters · filed 2024-11-01 | -$395.00K 10-Q · filed 2024-11-01 | -$623.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $49.00K 10-Q · filed 2024-08-07 | -$179.00K derived: sum of 3 quarters · filed 2024-08-07 | -$772.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $129.00K 10-Q · filed 2024-05-08 | -$99.00K derived: sum of 2 quarters · filed 2024-05-08 | -$692.00K derived: sum of 3 quarters · filed 2024-05-08 | -$960.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$821.00K derived: sum of 2 quarters · filed 2024-03-01 | -$1.09M derived: sum of 3 quarters · filed 2024-03-01 | -$1.21M 10-K · filed 2024-03-01 |
| 2022-09-30 | -$593.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$861.00K derived: sum of 2 quarters · filed 2023-11-07 | -$985.00K 10-Q · filed 2023-11-07 | -$895.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$268.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$392.00K 10-Q · filed 2023-08-07 | -$302.00K derived: sum of 3 quarters · filed 2023-08-07 | -$724.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$124.00K 10-Q · filed 2023-05-11 | -$34.00K derived: sum of 2 quarters · filed 2023-05-11 | -$456.00K derived: sum of 3 quarters · filed 2023-05-11 | -$682.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$332.00K derived: sum of 2 quarters · filed 2023-03-06 | -$558.00K derived: sum of 3 quarters · filed 2023-03-06 | -$1.68M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$648.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.77M 10-Q · filed 2022-11-03 | -$3.91M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.35M 10-Q · filed 2022-08-04 | -$3.49M derived: sum of 3 quarters · filed 2022-08-04 | -$2.25M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$1.12M 10-Q · filed 2022-05-11 | -$3.27M derived: sum of 2 quarters · filed 2022-05-11 | -$2.03M derived: sum of 3 quarters · filed 2022-05-11 | $1.69M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$903.00K derived: sum of 2 quarters · filed 2022-03-14 | $2.82M derived: sum of 3 quarters · filed 2022-03-14 | $2.25M 10-K · filed 2022-03-14 |
| 2020-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $4.96M derived: sum of 2 quarters · filed 2021-11-15 | $4.39M 10-Q · filed 2021-11-15 | $4.67M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $3.15M 10-Q · filed 2021-08-10 | $3.44M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$567.00K 10-Q · filed 2021-05-11 | -$284.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $791.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $508.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |